The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...
MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...
Cardiac Rhythm Management Devices Market Forecasted to Hit USD 39.07 Billion by 2035 – SNS Insider
Austin, United States, June 04, 2026 (GLOBE NEWSWIRE) -- “The Cardiac Rhythm Management Devices Market size was valued at USD 20.99 Billion in 2025 and is expected to reach USD 39.07 Billion by 2035, ...
The European Society of Cardiology (ESC) Guidelines on cardiac pacing and cardiac resynchronization therapy (CRT) are published online today in European Heart Journal. The use of pacemakers continues ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Results from the Cardiac Resynchronization—Heart Failure (CARE-HF) study support the use of implantable cardiac-resynchronization devices in patients with heart failure due to left-ventricular ...
Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
A health trust has apologised after it emerged that more than 160 patients with advanced heart conditions may have undergone an unnecessary procedure. The patients were fitted wit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results